Nikkei Plunges 5% as AI Stock Selloff Spreads Across Asia 
Dollar Slides as Softer US Inflation Dims Fed Rate Hike Expectations 
US Inflation Expected to Ease in June, but Fed Rate Hike Risks Persist Amid Middle East Tensions 
UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List 
U.S. Imposes 25% Tariff on Select Brazilian Imports After Section 301 Trade Investigation 
Gold Prices Head for Biggest Weekly Loss Since June as Fed Rate Outlook Weighs 
Oil Prices Climb as Trump Escalates Iran Pressure, Strait of Hormuz Risks Grow 
Gold Prices Slip as Oil Rally Fuels Inflation Fears, Strengthens Dollar 
Asian Stocks Rally as Cooling U.S. Inflation Boosts Fed Rate Cut Hopes 
Japan Core Inflation Seen Rising in June, Strengthening BOJ Rate Hike Outlook 
ECB's Kocher Says No Inflation Spillover Yet From Iran Conflict, Warns Risks Remain 
AI Chip Stocks Face Valuation Pressure as Investors Shift Toward Big Tech and Software 
US Stock Futures Hold Steady as Soft Inflation Data Eases Fed Rate Hike Fears 
IEA Warns China Rare Earth Export Curbs Could Threaten $6.5 Trillion in Global Production 
China Q2 2026 GDP Misses Forecast as Weak Domestic Demand Offsets Export Strength 
Asian Stocks Rise as Softer U.S. Inflation Boosts Sentiment Despite Middle East Tensions 
U.S. stock futures soared Monday after the White House and Chinese officials reached a trade agreement, easing tensions between the world's two largest economies and fueling optimism across key sectors.
Apple (NASDAQ:AAPL) jumped 6.5% following the deal and a report from The Wall Street Journal indicating the tech giant may raise iPhone prices without directly attributing it to tariffs. Amazon (NASDAQ:AMZN) surged 7.6%, driven by its reliance on Chinese supply chains and the improved trade outlook.
Chinese stocks also gained significantly. Alibaba (NYSE:BABA), JD.com (NASDAQ:JD), and Baidu (NASDAQ:BIDU) all traded sharply higher, reflecting investor confidence in renewed U.S.-China cooperation.
Energy stocks rose alongside oil prices. Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) climbed about 2%, boosted by expectations of increased demand from the world’s top two oil consumers.
On the downside, pharmaceutical stocks slipped after President Donald Trump announced plans to slash prescription drug prices by 59%, though details remain unclear. Pfizer (NYSE:PFE), Eli Lilly (NYSE:LLY), and Johnson & Johnson (NYSE:JNJ) all declined over 2%. Additionally, Novo Nordisk (NYSE:NVO) fell 3% after Eli Lilly’s Zepbound outperformed Wegovy in a weight-loss drug trial.
Alphabet (NASDAQ:GOOGL) gained 2.8% following a DA Davidson analyst note suggesting that breaking up the Google parent company could unlock significant shareholder value.
Polestar (NASDAQ:PSNY) rose 3.7% after the EV maker posted a narrowed quarterly loss, signaling progress in cost-cutting and premium model sales. Monday.Com (NASDAQ:MNDY) rallied 5.9% after surpassing first-quarter earnings estimates and offering upbeat full-year guidance.
Overall, the market welcomed the trade truce, with tech, energy, and select growth stocks leading the rally.
